UBC Medical Indonesia Past Earnings Performance
Past criteria checks 0/6
UBC Medical Indonesia's earnings have been declining at an average annual rate of -22.7%, while the Healthcare industry saw earnings growing at 3.7% annually. Revenues have been growing at an average rate of 46.5% per year. UBC Medical Indonesia's return on equity is 4.4%, and it has net margins of 1.6%.
Key information
-22.7%
Earnings growth rate
n/a
EPS growth rate
| Healthcare Industry Growth | 14.1% |
| Revenue growth rate | 46.5% |
| Return on equity | 4.4% |
| Net Margin | 1.6% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses Breakdown
How UBC Medical Indonesia makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 136,699 | 2,190 | 48,720 | 0 |
| 31 Dec 22 | 93,292 | 2,834 | 33,758 | 0 |
| 31 Dec 21 | 129,960 | 308 | 46,240 | 0 |
Quality Earnings: LABS has a high level of non-cash earnings.
Growing Profit Margin: LABS's current net profit margins (1.6%) are lower than last year (3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if LABS's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: LABS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: LABS had negative earnings growth (-22.7%) over the past year, making it difficult to compare to the Healthcare industry average (2.7%).
Return on Equity
High ROE: LABS's Return on Equity (4.4%) is considered low.